Feasibility Study of the "HemoTypeSC" Test for the Rapid Screening of Sickle Cell Disease in Côte D'Ivoire

Danho, et al.

Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study

Oluwole, et al.

Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India

Mukherjee, et al.

Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test

Steele, et al.

Acceptability of neonatal screening of the sickle cell disease during the pandemic of COVID-19 in Kisangani, Democratic Republic of the Congo

Kasai, et al.

Extremely high birth prevalence of sickle cell disease in rural Tanzania

Eastburg, et al.

HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda

Nankanja, et al.

A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies

Quinn, et al.

HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes

Adegoke, et al.

Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study

Nnodu, et al.

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges

Nnodu, et al.

New Sickle Cell Disease Testing on Nigerian Newborns
A newly released study seeks to increase sickle cell disease detection and treatment rates in newborn babies across Nigeria through HemoTypeSC, a rapid diagnostic test.

$2 Test Could Transform Sickle Cell Dx in Africa

An inexpensive, easy-to-use blood test could dramatically alter how sickle cell disease is diagnosed in Africa, where the often-undiagnosed disease is a leading cause of childhood mortality.

Advocacy for the Construction of a Sickle Cell Anemia Care Center in Côte d'Ivoire

Patrice Sékongo, country director of the European Institute for Cooperation and Development, called for mass screening and improved patient care thanks to a preventive system that is operational. In a presentation on the evolution of screening tools, Dr Yao Atimeré, a hematologist, presented the HemoTypeSC test, which can detect sickle cell anemia in ten minutes. A solution that comes to save lives.

Lack of Funds Hinders Govt’s Policy on SCD

Speaking at the presentation of HemoTypeSC, a care test for the detection of SCD, Dr. Alayo Sopekan, National Desk Officer on Sickle cell, Ministry of Health, [noted] that the country has put in place a policy to address the disease, such as testing for newborn, Sopekan, however, said the lack of fund has not allowed for the implementation.

A 10-minute Test Could Solve Africa’s Sickle Cell Disease Screening Problem for Newborns
A $2, 10-minute rapid point-of-care tool has brought the much elusive goal of rapidly screening Africa’s newborns for sickle cell disease (SCD), a major cause of child mortality, within reach.

New Sickle Cell Test Can Transform Screening

A new test that costs less than $2, requires only a small drop of blood, and can be performed in about 10 minutes could dramatically change the dynamics of sickle cell diagnosis in Africa.

Good News for Ivorian People. Now, They Can Know Their Hemoglobin Status Thanks to the HemoTypeSC Test...

Eugène Aka-Aouélé, Minister of Health and Dr. ADOUENI Katché Valéry, Coordinating Director of the National Program for Metabolic Diseases and NCD Prevention, have stated that the [HemoTypeSC test] will enable Ivory Coast to take a step forward in the fight against sickle cell disease.  

Experts Advocate Newborn Screening for Sickle Cell Disease

Professor Obiageli Nnodu, sickle cell disease expert from the University of Abuja, describes the current status of sickle cell disease in Nigeria and the results from early testing with HemoTypeSC™.

Rapid Result Test On Track to Transform Sickle Cell Disease Screening for Millions

Now, research shows that with a new rapid result test kit, a diagnosis of sickle cell disease may no longer be a death sentence for children in the most affected parts of the world...The test has the potential to be a game-changer for people with the disease who live in distressed areas around the world.

New Tools and Approaches Poised to Improve Diagnostics and Care for Millions Worldwide

A trial in Uganda showed a new test called HemoTypeSC was more than 99 percent accurate in detecting sickle cell disease in young children. The test requires only a small drop of blood and returns results in about 10 minutes, making it suitable for routine screening of newborns.

Television News Coverage of Accuracy+Feasibility Validation Study Workshop - Côte d'Ivoire